Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Here are seven articles Becker's Hospital Review published in the last week, highlighting HHS nominee Alex Azar's stance on high drug prices and the American Red Cross' urgent call for blood donors, among other topics.
The FDA approved Lupin Pharmaceutical's generic version of Roche's Tamiflu capsules Thursday, according to Money Control.
Stanford Blood Center in Palo Alto, Calif., which provides blood to four local hospitals, issued an urgent call for O-negative blood donations due to a critical shortage, reports Mercury News.
A strong customer-supply relationship is crucial to the success of a hospital's supply chain, according to Ruben Taborda, senior director of supply chain customer solutions at Johnson & Johnson Health Care Systems.
Mike Kaufmann, who assumed leadership of Dublin, Ohio-based Cardinal Health earlier this month, said the company's medical supply business will not become easily "commoditized" when brought toe-to-toe with other wholesale distributors, like Amazon, that aim to disrupt the business, according…
FDA Commissioner Scott Gottlieb, MD, outlined the agency's efforts to reduce drug prices, reflected on 2017's medical innovations and drafted goals for policy in 2018 in a blog post published Jan. 9.
The American Red Cross is experiencing a critical shortage of blood donations after a winter storm ripped through much of the Northeast last week, forcing the organization to cancel numerous blood drives, reports the Finger Lakes Times.
High drug prices were a hot topic of discussion at HHS secretary nominee Alex Azar's Senate confirmation hearing Tuesday, reports USA Today.
GlaxoSmithKline replaced roughly 50 of the 125 top managers, including the company's former CEO, since Emma Walmsley began in her role as head of the company last April. She said the restructuring represents an effort to increase diversity within the team…
Mylan confirmed Monday that it will complete a $1 billion share repurchase plan, which was previously approved by its board of directors.